Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by P&G Pharmaceuticals, Inc.
Lobbying Relationship
Bills mentioned
S.769: Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Sponsor: Blanche Lincoln (D-Ark.)
H.R.1894: Medicare Fracture Prevention and Osteoporosis Testing Act of 2009
Sponsor: Shelley Berkley (D-Nev.)
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.3200: America's Affordable Health Choices Act of 2009
Sponsor: John D. Dingell (D-Mich.)
S.1679: Affordable Health Choices Act
Sponsor: Tom Harkin (D-Iowa)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Sara Franko | Legislative Director/AA, Rep. Ted Strickland AA, Rep. Gerald Kleczka, LD/LA, Rep. Dennis Eckart |
| Drew Goesl | Chief of Staff, Cong. Mike Ross Communications Director, Sen. Blanche Lincoln |
| Zahra Buck | LA, Rep. Bennie Thompson Prof. Staff, House Homeland Security Cmte |
| Shannon Finley | n/a |
| Denise Henry | n/a |
| John D. Raffaelli | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate